Skip to content
OpenCapital
Get started

Dianthus Therapeutics DNTH Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$2.06M-22.1%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$1.03M-55.2%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$1.53M+2,835%

Other financials

Income statement

See full
Revenue$396.0K-81.8%
Operating income-$46.5M-40.3%
Net income-$40.8M-38.4%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$627.7M+6,105%
Total debt$1.4M-2.3%
Total equity$1.2B+266%
Total assets$1.2B+258%

Cash flow

See full
Operating cash flow-$28.9M-4.4%
CapEx$10.0K-58.3%
Free cash flow-$28.9M-4.4%

Valuation

See full
Market cap$4.51B+662%

Profitability

See full
Operating margin-4,558.4%-9,354pp
Net margin-4,104.8%-7,304pp
FCF margin-3,561.6%-6,956pp

Returns & leverage

See full
Return on equity-28.6%+3.2pp
Debt / equity0×0.0×
Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dianthus Therapeutics's accretion (amortization) of discounts and premiums, investments?
Dianthus Therapeutics (DNTH) reported accretion (amortization) of discounts and premiums, investments of $1.22M in Q1 2026.
How has Dianthus Therapeutics's accretion (amortization) of discounts and premiums, investments changed year-over-year?
Dianthus Therapeutics's accretion (amortization) of discounts and premiums, investments decreased by 35.9% year-over-year, from $1.9M to $1.22M.
What does accretion (amortization) of discounts and premiums, investments mean?
This represents the non-cash adjustment to net income resulting from the amortization of premiums or accretion of discounts on investment securities. It reflects the gradual adjustment of the carrying value of financial assets toward their face value over time. Investors use this to reconcile reported net income with actual cash flows generated from investment holdings.